Dr Michael Chengchun Li, MD - Medicare Student in an Organized Health Care Education/Training Program in Bryan, TX

Dr Michael Chengchun Li, MD is a medicare enrolled "Student In An Organized Health Care Education/training Program" physician in Bryan, Texas. His current practice location is 8441 Riverside Pkwy, Clinical Building 1, Suite 1400, Bryan, Texas. You can reach out to his office (for appointments etc.) via phone at (979) 436-9150.

Dr Michael Chengchun Li is licensed to practice in * (Not Available) (license number ) and he also participates in the medicare program. He does not accept medicare assignments directly but he may accept medicare through third-party (refer to Reassignment section below) and may also prescribe medicare part D drugs. His NPI Number is 1245811074.

Contact Information

Dr Michael Chengchun Li, MD
8441 Riverside Pkwy, Clinical Building 1, Suite 1400,
Bryan, TX 77807
(979) 436-9150
Not Available



Physician's Profile

Full NameDr Michael Chengchun Li
GenderMale
SpecialityStudent In An Organized Health Care Education/training Program
Location8441 Riverside Pkwy, Bryan, Texas
Accepts Medicare AssignmentsMedicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs.
  NPI Data:
  • NPI Number: 1245811074
  • Provider Enumeration Date: 04/14/2021
  • Last Update Date: 12/15/2023
  Medicare PECOS Information:
  • PECOS PAC ID: 3274985940
  • Enrollment ID: I20240118000379

Medical Identifiers

Medical identifiers for Dr Michael Chengchun Li such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1245811074NPI-NPPES

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
2084P0800XPsychiatry & Neurology - Psychiatry T9437 (Texas)Secondary
390200000XStudent In An Organized Health Care Education/training Program (* (Not Available))Primary

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Dr Michael Chengchun Li allows following entities to bill medicare on his behalf.
Entity NamePsychiatry Of Texas, Pllc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1013476027
PECOS PAC ID: 0345573598
Enrollment ID: O20190604000738

News Archive

Watson Laboratories sued over ANDA filing for generic Opana ER

Watson Pharmaceuticals, Inc., a leading specialty pharmaceutical company, today confirmed that its subsidiary, Watson Laboratories, Inc., has been sued by Endo Pharmaceuticals Inc. and Penwest Pharmaceuticals Co. in connection with the filing of Watson's Abbreviated New Drug Application (ANDA) for Oxymorphone Hydrochloride Extended-Release Tablets, 40mg.

Great Place to Work Institute honors Genencor with prestigious award

Genencor, a division of Danisco A/S, announced today that the company was ranked #7 on the list of The Netherlands Great Places to Work 2011 in the category of "Large & Multinational Companies" by the Great Place to Work Institute.

DCIS patients with high mammographic density face subsequent breast cancer risk

Researchers at Kaiser Permanente have found that patients with a very early form of breast cancer (ductal carcinoma in situ or DCIS) who have higher mammographic density may be at increased risk for subsequent breast cancer, especially in the breast opposite to the one with the initial cancer.

States plot Medicaid managed care changes; Kansas managed care plan met with skepticism

In Ohio, Molina Healthcare loses its Medicaid managed care contract. In Texas, a plan to save money by incorporating Medicaid drug benefits into a managed care program gets pushback. And, Kansas counties weigh in on a plan to shift Medicaid beneficiaries to managed care.

Genentech is again the world's most respected biopharmaceutical employer

Science annual survey of Top Employers polls employees in the biotechnology, biopharmaceutical, pharmaceutical, and related industries. Respondents to the web-based survey are asked to rate companies based on 23 driving characteristics, including financial strength, easy adaptation to change, and a research-driven environment.

Read more Medical News

› Verified 9 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Michael Chengchun Li is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Dr Michael Chengchun Li, MD
8441 Riverside Pkwy, Clinical Building 1, Suite 1400,
Bryan, TX 77807

Ph: (979) 436-9150
Dr Michael Chengchun Li, MD
8441 Riverside Pkwy, Clinical Building 1, Suite 1400,
Bryan, TX 77807

Ph: (979) 436-9150

News Archive

Watson Laboratories sued over ANDA filing for generic Opana ER

Watson Pharmaceuticals, Inc., a leading specialty pharmaceutical company, today confirmed that its subsidiary, Watson Laboratories, Inc., has been sued by Endo Pharmaceuticals Inc. and Penwest Pharmaceuticals Co. in connection with the filing of Watson's Abbreviated New Drug Application (ANDA) for Oxymorphone Hydrochloride Extended-Release Tablets, 40mg.

Great Place to Work Institute honors Genencor with prestigious award

Genencor, a division of Danisco A/S, announced today that the company was ranked #7 on the list of The Netherlands Great Places to Work 2011 in the category of "Large & Multinational Companies" by the Great Place to Work Institute.

DCIS patients with high mammographic density face subsequent breast cancer risk

Researchers at Kaiser Permanente have found that patients with a very early form of breast cancer (ductal carcinoma in situ or DCIS) who have higher mammographic density may be at increased risk for subsequent breast cancer, especially in the breast opposite to the one with the initial cancer.

States plot Medicaid managed care changes; Kansas managed care plan met with skepticism

In Ohio, Molina Healthcare loses its Medicaid managed care contract. In Texas, a plan to save money by incorporating Medicaid drug benefits into a managed care program gets pushback. And, Kansas counties weigh in on a plan to shift Medicaid beneficiaries to managed care.

Genentech is again the world's most respected biopharmaceutical employer

Science annual survey of Top Employers polls employees in the biotechnology, biopharmaceutical, pharmaceutical, and related industries. Respondents to the web-based survey are asked to rate companies based on 23 driving characteristics, including financial strength, easy adaptation to change, and a research-driven environment.

Read more News

› Verified 9 days ago



Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.